Retireful LLC Takes Position in Align Technology, Inc. (NASDAQ:ALGN)

Retireful LLC purchased a new stake in Align Technology, Inc. (NASDAQ:ALGN - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 8,143 shares of the medical equipment provider's stock, valued at approximately $2,231,000.

Several other institutional investors have also modified their holdings of the business. KB Financial Partners LLC purchased a new position in Align Technology in the first quarter worth approximately $26,000. Cornerstone Planning Group LLC acquired a new position in shares of Align Technology during the second quarter worth $29,000. Huntington National Bank increased its holdings in Align Technology by 94.9% in the third quarter. Huntington National Bank now owns 115 shares of the medical equipment provider's stock valued at $35,000 after buying an additional 56 shares during the last quarter. First Manhattan CO. LLC. lifted its holdings in Align Technology by 593.8% during the 1st quarter. First Manhattan CO. LLC. now owns 111 shares of the medical equipment provider's stock worth $37,000 after buying an additional 95 shares during the last quarter. Finally, ST Germain D J Co. Inc. acquired a new position in shares of Align Technology during the 2nd quarter worth about $44,000. Institutional investors and hedge funds own 88.43% of the company's stock.

Analyst Ratings Changes

Several brokerages have recently weighed in on ALGN. Leerink Partnrs reissued a "market perform" rating on shares of Align Technology in a research report on Monday, February 26th. UBS Group upped their target price on shares of Align Technology from $200.00 to $260.00 and gave the company a "neutral" rating in a report on Tuesday, January 30th. The Goldman Sachs Group boosted their price target on shares of Align Technology from $197.00 to $225.00 and gave the company a "sell" rating in a research report on Friday, February 2nd. Piper Sandler raised their price objective on Align Technology from $335.00 to $355.00 and gave the stock an "overweight" rating in a report on Thursday, March 14th. Finally, SVB Leerink assumed coverage on Align Technology in a report on Monday, February 26th. They issued a "market perform" rating and a $310.00 target price for the company. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $334.45.

Insider Transactions at Align Technology

In other news, EVP Emory Wright sold 2,524 shares of the firm's stock in a transaction dated Wednesday, February 7th. The shares were sold at an average price of $287.45, for a total transaction of $725,523.80. Following the completion of the transaction, the executive vice president now owns 709 shares in the company, valued at approximately $203,802.05. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In related news, EVP Emory Wright sold 2,524 shares of the company's stock in a transaction that occurred on Wednesday, February 7th. The shares were sold at an average price of $287.45, for a total value of $725,523.80. Following the completion of the sale, the executive vice president now owns 709 shares in the company, valued at approximately $203,802.05. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Joseph Lacob sold 15,000 shares of the stock in a transaction on Thursday, February 29th. The shares were sold at an average price of $303.22, for a total value of $4,548,300.00. Following the completion of the sale, the director now owns 131,994 shares of the company's stock, valued at approximately $40,023,220.68. The disclosure for this sale can be found here. In the last three months, insiders sold 27,524 shares of company stock valued at $8,403,924. Company insiders own 0.64% of the company's stock.

Align Technology Stock Up 0.8 %

Shares of NASDAQ ALGN traded up $2.63 during trading on Friday, reaching $317.58. 593,038 shares of the stock were exchanged, compared to its average volume of 487,825. The company has a market capitalization of $23.85 billion, a price-to-earnings ratio of 54.57, a price-to-earnings-growth ratio of 5.67 and a beta of 1.65. The business's 50-day moving average price is $306.02 and its 200 day moving average price is $269.55. Align Technology, Inc. has a twelve month low of $176.34 and a twelve month high of $413.20.

Align Technology (NASDAQ:ALGN - Get Free Report) last released its quarterly earnings data on Wednesday, January 31st. The medical equipment provider reported $1.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.78 by $0.13. Align Technology had a return on equity of 13.88% and a net margin of 11.52%. The business had revenue of $956.73 million during the quarter, compared to analyst estimates of $928.57 million. As a group, sell-side analysts expect that Align Technology, Inc. will post 7.65 earnings per share for the current fiscal year.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.